When Trai Hume signed for Sunderland for just £200,000 when they were in League One, he would not have in his wildest dreams ...

Annika Sorenstam becomes the first woman to play in a PGA Tour event in 58 years when she shoots a 71 in the first round of the Colonial in Fort Worth, Texas. Sorenstam misses the cut the next day by ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

BAE Systems has opened the door to talks with the UK about an alternative armoured vehicle deal as a plan to buy rival Ajax staggers on despite catastrophic flaws. Britain’s biggest defence contractor ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

General Dynamics said the safety of soldiers 'is, and has always been, our highest priority'. Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister ...

Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister acknowledging more work is needed to "rebuild confidence" in the transportation. Testing of the ...

Eli Lilly has agreed to acquire Ajax Therapeutics in a deal worth up to $2.3 billion, strengthening its position in blood cancer research. The acquisition brings Ajax’s pipeline of next generation JAK ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...